Main Menu

Our Work

Amgen Inc. v. Sanofi Aventisub LLC and Regeneron Pharmaceuticals, Inc.

In Amgen v. Sanofi, supported professor Ernst Berndt of the Massachusetts Institute of Technology in his application of the four eBay factors after Sanofi's biologic Praluent was found to infringe on patents related to Amgen's biologic Repatha. Among other topics, Dr. Berndt discussed the importance of intellectual property rights in providing the necessary incentives to develop new biologic treatments. A decision on a permanent injunction is expected by the end of 2016.

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.